Giulia Belvederi

发表论文 1 篇 · 总被引 22 次 · h-index 1

代表论文

• Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies (2024 · Kidney International Reports · 被引 33)